← Browse by Condition
Medical Condition

stereotactic radiation

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06702826 Phase 2
Recruiting

Cadonilimab Combined With Stereotactic Radiotherapy as Second-line Treatment for Brain Metastases

Enrollment
20 pts
Location
China
Sponsor
Rongrong Zhou
View Trial →